Singapore markets closed
Straits Times Index
3,130.24 +15.16 (+0.49%) Nikkei
25,937.21 -484.84 (-1.83%) Hang Seng
17,222.83 +56.96 (+0.33%) FTSE 100
6,893.81 +12.22 (+0.18%) BTC-USD
19,723.20 +337.69 (+1.74%) CMC Crypto 200
450.00 +6.57 (+1.48%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:33PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 75.41B |
| Enterprise value | 70.55B |
| Trailing P/E | 13.84 |
| Forward P/E | 14.27 |
| PEG Ratio (5 yr expected) | 4.64 |
| Price/sales (ttm) | 5.53 |
| Price/book (mrq) | 3.65 |
| Enterprise value/revenue | 4.96 |
| Enterprise value/EBITDA | 10.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.28 |
| 52-week change 3 | 21.20% |
| S&P500 52-week change 3 | -16.45% |
| 52-week high 3 | 754.67 |
| 52-week low 3 | 538.01 |
| 50-day moving average 3 | 635.32 |
| 200-day moving average 3 | 636.72 |
Share statistics
| Avg vol (3-month) 3 | 678.36k |
| Avg vol (10-day) 3 | 790.3k |
| Shares outstanding 5 | 107.19M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 102.28M |
| % held by insiders 1 | 2.59% |
| % held by institutions 1 | 89.79% |
| Shares short (30 Aug 2022) 4 | 2.91M |
| Short ratio (30 Aug 2022) 4 | 5.37 |
| Short % of float (30 Aug 2022) 4 | 2.83% |
| Short % of shares outstanding (30 Aug 2022) 4 | 2.67% |
| Shares short (prior month 28 Jul 2022) 4 | 3.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 39.97% |
| Operating margin (ttm) | 49.77% |
Management effectiveness
| Return on assets (ttm) | 18.18% |
| Return on equity (ttm) | 31.76% |
Income statement
| Revenue (ttm) | 14.23B |
| Revenue per share (ttm) | 133.27 |
| Quarterly revenue growth (yoy) | -44.40% |
| Gross profit (ttm) | 10.73B |
| EBITDA | 7.38B |
| Net income avi to common (ttm) | 5.69B |
| Diluted EPS (ttm) | 50.63 |
| Quarterly earnings growth (yoy) | -72.50% |
Balance sheet
| Total cash (mrq) | 7.57B |
| Total cash per share (mrq) | 70.78 |
| Total debt (mrq) | 2.7B |
| Total debt/equity (mrq) | 13.06 |
| Current ratio (mrq) | 5.12 |
| Book value per share (mrq) | 192.62 |
Cash flow statement
| Operating cash flow (ttm) | 8.45B |
| Levered free cash flow (ttm) | 6.24B |
© 2022 Yahoo. All rights reserved.
